BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1721294)

  • 1. Site of action of cyclosporine and FK 506 in the pathways of communication between the T-lymphocyte antigen receptor and the early activation genes.
    Ullman KS; Flanagan WM; Cothesy B; Kuo P; Northrop JP; Crabtree GR
    Transplant Proc; 1991 Dec; 23(6):2845. PubMed ID: 1721294
    [No Abstract]   [Full Text] [Related]  

  • 2. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
    Hultsch T; Hohman RJ
    Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 4. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
    Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
    J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
    Schreier MH; Baumann G; Zenke G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner.
    Su MS; Semerjian A
    Transplant Proc; 1991 Dec; 23(6):2912-5. PubMed ID: 1721310
    [No Abstract]   [Full Text] [Related]  

  • 8. [A second target of cyclosporin A and FK506].
    Matsuda S; Koyasu S
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1823-31. PubMed ID: 10936966
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive drugs reveal similarities between IgE receptor and T-cell receptor signaling pathways.
    Hohman RJ; Hultsch T
    Transplant Proc; 1991 Dec; 23(6):2907-11. PubMed ID: 1836288
    [No Abstract]   [Full Text] [Related]  

  • 10. FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal.
    Metcalfe S; Alexander D; Turner J
    Cell Immunol; 1994 Oct; 158(1):46-58. PubMed ID: 7522130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of FK 506 on in vivo immunity in comparison to cyclosporine.
    Takaori K; Nio Y; Inoue K; Aung T; Tun T; Hashida T; Yasuhara M; Hori R; Tobe T
    Transplant Proc; 1991 Dec; 23(6):2948-9. PubMed ID: 1721322
    [No Abstract]   [Full Text] [Related]  

  • 12. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of dietary n-3 fatty acids on T cell activation and T cell receptor-mediated signaling in a murine model.
    McMurray DN; Jolly CA; Chapkin RS
    J Infect Dis; 2000 Sep; 182 Suppl 1():S103-7. PubMed ID: 10944491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.
    Tong-Starkesen SE; Luciw PA; Peterlin BM
    J Immunol; 1989 Jan; 142(2):702-7. PubMed ID: 2536062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial immunosuppressive effect of combined use of FK 506 and cyclosporine assessed by proliferative responses of cloned human T cells.
    Matsuura T; Shinohara Y; Hara Y; Imanishi M; Nishioka T; Kunikata S; Kanda H; Akiyama T; Kurita T
    Transplant Proc; 1991 Dec; 23(6):2931-2. PubMed ID: 1721316
    [No Abstract]   [Full Text] [Related]  

  • 16. Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro.
    Matsuura T; Negita M; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Akiyama T
    Transplant Proc; 1992 Feb; 24(1):410-2. PubMed ID: 1371623
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
    Tamura K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of FK 506 and cyclosporine on T-cell tolerance: inhibition of a "protective" mechanism that regulates activation-induced apoptosis in developing thymocytes.
    McCarthy SA; Mainwaring MS; Cairns JS
    Transplant Proc; 1991 Dec; 23(6):2925-7. PubMed ID: 1721314
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor.
    Cantrell DA; Izquierdo M; Reif K; Woodrow M
    Semin Immunol; 1993 Oct; 5(5):319-26. PubMed ID: 8260648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK 506 and cyclosporin each block antigen-induced T cell receptor signalling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes.
    Metcalfe S; Alexander D; Turner J
    Transpl Int; 1994; 7 Suppl 1():S549-51. PubMed ID: 11271304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.